Early Identification of Sepsis-associated Acute Kidney Injury Using Ultrasonography Measurements and Renin and Angiotensin Levels in Children and Adults.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sepsis
- Sponsor
- Northwell Health
- Enrollment
- 74
- Locations
- 1
- Primary Endpoint
- Difference in serum renin in sepsis
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI.
Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients.
Enzyme-linked immunosorbent assays (ELISA) with be run on serum plasma to compare the renin-angiotensin-aldosterone system (RAAS) between groups.
Detailed Description
Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with AKI vs without AKI. Powered to collect 74 patients total (37 sepsis,37 healthy) with enrollment ratio 1:1 and expected different of 50% in renin levels, this provides 80% power at an alpha of 0.05. Sepsis identified as pediatric Sequential Organ Failure Assessment (pSOFA) \>/= 2 + infection and/or Phoenix sepsis criteria. Collecting blood samples on subsequent days of hospitalization. For healthy patients, a one-time blood draw will be obtained . Renal ultrasound will be performed on day 1, 2 and 3 of hospitalization. Blood will be collected and plasma stored at -80 degrees Celsius. Plasma thawed in batches and ELISAs for RAAS components. Demographic data will be collected.
Investigators
Eligibility Criteria
Inclusion Criteria
- •pediatric patients age 1 days - 18 years old with sepsis or age 1 day - 18 years and healthy.
Exclusion Criteria
- •-pre-existing end stage renal disease (ESRD), chronic renal failure (CRF), home use of angiotensin converting enzyme inhibitor(ACE) or angiotensin receptor blocker(ARB) medications, pre-existing congestive heart failure (CHF), and unrepaired congenital heart disease
Outcomes
Primary Outcomes
Difference in serum renin in sepsis
Time Frame: For sepsis cohort point 1 collection within the first 48 hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94 hours. For the healthy cohort blood drawn at a single time point up to 24 hours
Comparison between healthy and septic subjects serum renin levels
Secondary Outcomes
- Aberrations in the renin angiotensin aldosterone system (RAAS) in sepsis associated acute kidney injury(For sepsis cohort point 1 collection within the first 48 hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94 hours.)
- Aberrations in the renin angiotensin aldosterone system (RAAS) in sepsis versus healthy patients(For sepsis cohort point 1 collection within the first 48hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94hours. For the healthy cohort blood drawn at a single time point.)
- Changes in renal blood flow on Ultrasound in Sepsis(For sepsis cohort point 1 collection within the first 48 hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94 hours.)
- Renal blood flow and RAAS in sepsis(For sepsis cohort point 1 collection within the first 48 hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94hours.)
- Septic induced kidney injury will be associated with alterations in renal blood flow(For sepsis cohort point 1 collection within the first 48 hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94 hours.)
- Changes in the components of the RAAS over the first three days in sepsis(For sepsis cohort point 1 collection within the first 48hours from of meeting sepsis criteria, point 2: 48-72 hours and point 3: 72-94hours.)